Akèy › Tit travay › Sr. Validation Engineer
Sr. Validation Engineer: Salè H-1B
98 aplikasyon kondisyon travay te itilize tit travay Sr. Validation Engineer. Salè baz medyàn ofri $115,000; mwatye mitan $95,000–$133,120.
Demann (LCA)98
Salè medyan ofri$115,000
Mwatye salè yo$95,000–$133,120
10yèm–90yèm pousantaj$85,808–$140,000
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| United Pharma Technologies, Inc. | 7 | $120,640 |
| Intellectt, Inc. | 5 | $104,000 |
| Techno Pro Solutions, Inc. | 5 | $88,234 |
| Patel Consultants Corporation | 5 | $145,600 |
| Pi Square Technologies LLC | 4 | $83,000 |
| Montage Semiconductor, Inc. | 4 | $132,000 |
| IZiel Healthcare Inc | 4 | $93,500 |
| VAStek Inc. | 3 | — |
| Pharma Tek Solutions, Inc. | 3 | $140,000 |
| Fusion Life Sciences Technologies LLC | 3 | $133,120 |
| White Collar Technologies, Inc | 2 | $93,465 |
| Shire Human Genetic Therapies Inc. | 2 | $131,560 |
| Novozen Healthcare LLC. | 2 | $120,141 |
| Draeger Medical Systems, Inc. | 2 | $115,000 |
| Renesas Electronics America Inc. | 2 | $125,000 |
| Barry-Wehmiller Companies, Inc. | 2 | $140,000 |
| Validit Solutions LLC | 2 | $125,632 |
| Flextronics International USA, Inc. | 2 | $104,425 |
| Amstergen Life Sciences, LLC | 1 | $113,963 |
| Genentech, Inc. | 1 | $106,350 |
| Cangene bioPharma LLC | 1 | $135,013 |
| Global Pharmatek LLC | 1 | $85,779 |
| LS Solutions, Inc. | 1 | $120,000 |
| ITConsulting Services, Inc. | 1 | $84,240 |
| QPharma, Inc. | 1 | $90,000 |
| Rivian Automotive, LLC | 1 | $133,000 |
| Renesas Design North America Inc. | 1 | $130,000 |
| AM Logic Corporation | 1 | $95,000 |
| ZT Group Int'l, Inc. | 1 | $73,278 |
| The Veritas Healthcare Solutions LLC | 1 | $82,118 |
| Akshaya Inc. | 1 | $132,870 |
| JOINN Biologics US Inc | 1 | $113,850 |
| Hyde Engineering and Consulting, Inc. | 1 | $126,500 |
| Sierra Wireless America, Inc. | 1 | $120,000 |
| Plastikon Healthcare, LLC | 1 | $115,000 |
| Amerisourcebergen Services Corporation | 1 | $140,415 |
| Illumina, Inc. | 1 | $108,139 |
| TCT Mobile, Inc. | 1 | $67,309 |
| Grand River Aseptic Manufacturing | 1 | $120,000 |
| CSL Behring L.L.C. | 1 | $104,542 |
| Rivian and VW Group Technology, LLC | 1 | $146,000 |
| West Pharmaceutical Services, Inc. | 1 | $92,102 |
| NorthStar Medical Radioisotopes, LLC | 1 | $133,306 |
| QvalFocus Inc. | 1 | $95,000 |
| Cambrex Charles City, Inc. | 1 | $98,962 |
| Valsource, Inc. | 1 | $125,611 |
| BioCentriq | 1 | $140,000 |
| Real Scientific, Inc. | 1 | $140,000 |
| SAFC Carlsbad, Inc. | 1 | $140,000 |
| Verista, Inc. | 1 | $115,585 |
| Clarion Corporation of America | 1 | $113,123 |
| Civica, Inc. | 1 | $150,000 |
| Forge Biologics | 1 | $122,000 |
| Amneal Pharmaceuticals, LLC | 1 | $110,000 |
| ND Global Consulting Services Inc. | 1 | $85,925 |
| Thundersoft America Corporation | 1 | $113,300 |
| Vidlexinfo LLC | 1 | $113,173 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $70,294 |
| Nivo II (kalifye) | $95,000 |
| Nivo III (eksperyans) | $117,500 |
| Nivo IV (plen kompetans) | $134,701 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 25 | $113,963 |
| FY2024 | 25 | $104,542 |
| FY2025 | 27 | $133,120 |
| FY2026 | 16 | $118,240 |
Vil yo
- Rensselaer, NY5
- Andover, MA4
- Grand Rapids, MI3
- Suwanee, GA3
- West Greenwich, RI2
- Lawrence, KS2
- Princeton, NJ2
- Norwood, MA2
- Tustin, CA2
- Swiftwater, PA2
- Danbury, CT2
- Auburn Hills, MI2
- Lexington, MA2
- San Diego, CA2
- East Hanover, NJ2
- Petersburg, VA2
- Boxborough, MA2
- Bloomington, IN2
- Minneapolis, MN2
- Buffalo Grove, IL2
- Warminster, PA1
- Plymouth, MN1
- Vacaville, CA1
- Rockville, MD1
- Milford, MA1
- Farmington Hills, MI1
- Morris Plains, NJ1
- Providence, RI1
- Pompton Plains, NJ1
- Johns Creek, GA1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).